Heparan sulfate proteoglycans in beta cells provide a critical link between endoplasmic reticulum stress, oxidative stress and type 2 diabetes

PLoS One. 2021 Jun 4;16(6):e0252607. doi: 10.1371/journal.pone.0252607. eCollection 2021.

Abstract

Heparan sulfate proteoglycans (HSPGs) consist of a core protein with side chains of the glycosaminoglycan heparan sulfate (HS). We have previously identified (i) the HSPGs syndecan-1 (SDC1), and collagen type XVIII (COL18) inside mouse and human islet beta cells, and (ii) a critical role for HS in beta cell survival and protection from reactive oxygen species (ROS). The objective of this study was to investigate whether endoplasmic reticulum (ER) stress contributes to oxidative stress and type 2 diabetes (T2D) by depleting beta cell HSPGs/HS. A rapid loss of intra-islet/beta cell HSPGs, HS and heparanase (HPSE, an HS-degrading enzyme) accompanied upregulation of islet ER stress gene expression in both young T2D-prone db/db and Akita Ins2WT/C96Y mice. In MIN6 beta cells, HSPGs, HS and HPSE were reduced following treatment with pharmacological inducers of ER stress (thapsigargin or tunicamycin). Treatment of young db/db mice with Tauroursodeoxycholic acid (TUDCA), a chemical protein folding chaperone that relieves ER stress, improved glycemic control and increased intra-islet HSPG/HS. In vitro, HS replacement with heparin (a highly sulfated HS analogue) significantly increased the survival of wild-type and db/db beta cells and restored their resistance to hydrogen peroxide-induced death. We conclude that ER stress inhibits the synthesis/maturation of HSPG core proteins which are essential for HS assembly, thereby exacerbating oxidative stress and promoting beta cell failure. Diminished intracellular HSPGs/HS represent a previously unrecognized critical link bridging ER stress, oxidative stress and beta cell failure in T2D.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factors / genetics
  • Activating Transcription Factors / metabolism
  • Animals
  • Cell Survival / drug effects
  • Cells, Cultured
  • Diabetes Mellitus, Type 2 / metabolism
  • Diabetes Mellitus, Type 2 / pathology*
  • Disease Models, Animal
  • Endoplasmic Reticulum Stress*
  • Glucuronidase / genetics
  • Glucuronidase / metabolism
  • Heparan Sulfate Proteoglycans / metabolism*
  • Heparitin Sulfate / metabolism
  • Humans
  • Hydrogen Peroxide / pharmacology
  • Insulin-Secreting Cells / cytology
  • Insulin-Secreting Cells / metabolism
  • Lactones / pharmacology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Obese
  • Oxidative Stress*
  • Sesquiterpenes / pharmacology
  • Transcription Factor CHOP / genetics
  • Transcription Factor CHOP / metabolism
  • Up-Regulation / drug effects

Substances

  • Activating Transcription Factors
  • Ddit3 protein, mouse
  • Heparan Sulfate Proteoglycans
  • Lactones
  • Sesquiterpenes
  • Transcription Factor CHOP
  • thapsigargicin
  • Heparitin Sulfate
  • Hydrogen Peroxide
  • heparanase
  • Glucuronidase

Grants and funding

This work was supported by grants from The National Health and Medical Research Council of Australia (NHMRC; www.nhmrc.gov.au<http://www.nhmrc.gov.au>), #1065068, to CJS and SRB and the Diabetes Australia Research Trust (www.diabetesaustralia.com.au/research-advocacy/research/<http://www.diabetesaustralia.com.au/research-advocacy/research/>) to CJS. PI-88 compound for in vitro studies was a gift from Progen Pharrmaceuticals Limited (Brisbane, Queensland, Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.